BioCentury | Sep 6, 2004
Strategy

Back to School 2004: Asset accumulation

...company acquired a controlling interest in Scriptgen Pharmaceuticals Inc. (Waltham, Mass.) for an undisclosed amount of cash. Scriptgen...
...Affinity Screen) screening platform, which measures the affinity of compounds for target proteins, comes from Scriptgen...
...ANDS had three components: a medicinal chemistry core, the EMBL IP for RNA, and the Scriptgen...
BioCentury | Jul 31, 2000
Tools & Techniques

PathoSeq goes functional

...INCY's first effort to include microbial functional genomics information in PathoSeq. In 1996 INCY and Scriptgen Pharmaceuticals Inc....
...1996) . But according to INCY, those data were never added to the PathoSeq database. Scriptgen...
BioCentury | Jul 3, 2000
Company News

Anadys, Scriptgen, EMBL deal

...Scriptgen changed its name to Anadys, and will focus on drug discovery for infectious diseases. Scriptgen...
...Corp. (PHA, Peapack. N.J.). (Board, Management, B8; SAB, B9) Anadys Pharmaceuticals Inc., San Diego, Calif. Scriptgen Pharmaceuticals Inc....
BioCentury | Jul 3, 2000
Company News

Anadys board of directors update

...Scriptgen becomes Anadys, B3; Management, below, SAB, B9) Anadys Pharmaceuticals Inc., San Diego, Calif. Business: Infectious...
BioCentury | Jul 3, 2000
Company News

Anadys scientific advisory board update

...Scriptgen becomes Anadys, B3; Board, Management, B8) Anadys Pharmaceuticals Inc., San Diego, Calif. Business: Drug Discovery...
BioCentury | Jul 3, 2000
Company News

Anadys management update

...Scriptgen becomes Anadys, B3; Board, B8; SAB, below) Anadys Pharmaceuticals Inc. , San Diego, Calif. Business...
...Biosciences Corp. ; Mark Weedon as executive chairman, formerly president, CEO and a director of Scriptgen Pharmaceuticals Inc....
...Scriptgen Pharmaceuticals Inc.; and Michael Heslop as VP of commercial development, formerly VP of business development at Scriptgen Pharmaceuticals Inc. WIR...
BioCentury | May 15, 2000
Company News

Scriptgen management update

Scriptgen Pharmaceuticals Inc. , Waltham, Mass. Business: Drug discovery Hired: Devron Averett as SVP of research, development and medical, formerly department head of molecular and cellular virology at Glaxo Wellcome plc WIR Staff...
BioCentury | Apr 3, 2000
Company News

Scriptgen, Simulations Plus Inc. sales and marketing update

...SIMU granted Scriptgen a non-exclusive license to its GastroPlus and QMPRPlus drug absorption simulation software. Scriptgen Pharmaceuticals Inc....
BioCentury | Mar 29, 2000
Company News

Scriptgen licenses simulation software

...Simulations Plus (SIMU) granted Scriptgen (Waltham, Mass.) a license to its GastroPlus and QMPRPlus absorption simulation...
BioCentury | Mar 13, 2000
Company News

Scriptgen, 3-Dimensional drug discovery news

...Ligand Affinity Screen (ATLAS), and Scriptgen received a non-exclusive license to 3-D's ThermoFluor assay technology. Scriptgen Pharmaceuticals Inc....
Items per page:
1 - 10 of 38
BioCentury | Sep 6, 2004
Strategy

Back to School 2004: Asset accumulation

...company acquired a controlling interest in Scriptgen Pharmaceuticals Inc. (Waltham, Mass.) for an undisclosed amount of cash. Scriptgen...
...Affinity Screen) screening platform, which measures the affinity of compounds for target proteins, comes from Scriptgen...
...ANDS had three components: a medicinal chemistry core, the EMBL IP for RNA, and the Scriptgen...
BioCentury | Jul 31, 2000
Tools & Techniques

PathoSeq goes functional

...INCY's first effort to include microbial functional genomics information in PathoSeq. In 1996 INCY and Scriptgen Pharmaceuticals Inc....
...1996) . But according to INCY, those data were never added to the PathoSeq database. Scriptgen...
BioCentury | Jul 3, 2000
Company News

Anadys, Scriptgen, EMBL deal

...Scriptgen changed its name to Anadys, and will focus on drug discovery for infectious diseases. Scriptgen...
...Corp. (PHA, Peapack. N.J.). (Board, Management, B8; SAB, B9) Anadys Pharmaceuticals Inc., San Diego, Calif. Scriptgen Pharmaceuticals Inc....
BioCentury | Jul 3, 2000
Company News

Anadys board of directors update

...Scriptgen becomes Anadys, B3; Management, below, SAB, B9) Anadys Pharmaceuticals Inc., San Diego, Calif. Business: Infectious...
BioCentury | Jul 3, 2000
Company News

Anadys scientific advisory board update

...Scriptgen becomes Anadys, B3; Board, Management, B8) Anadys Pharmaceuticals Inc., San Diego, Calif. Business: Drug Discovery...
BioCentury | Jul 3, 2000
Company News

Anadys management update

...Scriptgen becomes Anadys, B3; Board, B8; SAB, below) Anadys Pharmaceuticals Inc. , San Diego, Calif. Business...
...Biosciences Corp. ; Mark Weedon as executive chairman, formerly president, CEO and a director of Scriptgen Pharmaceuticals Inc....
...Scriptgen Pharmaceuticals Inc.; and Michael Heslop as VP of commercial development, formerly VP of business development at Scriptgen Pharmaceuticals Inc. WIR...
BioCentury | May 15, 2000
Company News

Scriptgen management update

Scriptgen Pharmaceuticals Inc. , Waltham, Mass. Business: Drug discovery Hired: Devron Averett as SVP of research, development and medical, formerly department head of molecular and cellular virology at Glaxo Wellcome plc WIR Staff...
BioCentury | Apr 3, 2000
Company News

Scriptgen, Simulations Plus Inc. sales and marketing update

...SIMU granted Scriptgen a non-exclusive license to its GastroPlus and QMPRPlus drug absorption simulation software. Scriptgen Pharmaceuticals Inc....
BioCentury | Mar 29, 2000
Company News

Scriptgen licenses simulation software

...Simulations Plus (SIMU) granted Scriptgen (Waltham, Mass.) a license to its GastroPlus and QMPRPlus absorption simulation...
BioCentury | Mar 13, 2000
Company News

Scriptgen, 3-Dimensional drug discovery news

...Ligand Affinity Screen (ATLAS), and Scriptgen received a non-exclusive license to 3-D's ThermoFluor assay technology. Scriptgen Pharmaceuticals Inc....
Items per page:
1 - 10 of 38